COG7 Gene Glycosylation Disorder Type 2E Genetic Test sale cost 4400 AED
ALG12 Gene Glycosylation Disorder Type 1G Genetic Test sale cost 4400 AED ALG12 Gene Glycosylation Disorder Type 1G Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
HLCS Gene Holocarboxylase Synthetase Deficiency Genetic Test sale cost 4400 AED HLCS Gene Holocarboxylase Synthetase Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

COG7 Gene Glycosylation Disorder Type 2E Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COG7 Gene Glycosylation Disorder Type 2E Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COG7 gene, which are implicated in Congenital Disorders of Glycosylation Type IIe (CDG-IIe). This condition is a rare genetic disorder that affects the normal process of glycosylation – the attachment of sugars to proteins and lipids, which is crucial for various cellular functions. Symptoms of the disorder can include developmental delay, neurological issues, and abnormalities in various organs.

The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect mutations in the COG7 gene, helping in the accurate diagnosis of CDG-IIe. This information is vital for understanding the prognosis of the disorder and can guide treatment and management strategies. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the test ensures accuracy and reliability, providing essential genetic insights for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COG7 Gene Glycosylation Disorder Type 2E Genetic Test

At DNA Labs UAE, we offer the COG7 Gene Glycosylation Disorder Type 2E Genetic Test, a comprehensive genetic test that helps identify mutations or variations in the COG7 gene. This test plays a crucial role in diagnosing individuals suspected of having a glycosylation disorder type 2E.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Symptoms and Diagnosis

Glycosylation disorder type 2E is characterized by a range of symptoms, including developmental delays, intellectual disability, seizures, and various physical abnormalities. To ensure accurate diagnosis, it is essential to have a clinical history of the patient who is undergoing the COG7 Gene Glycosylation Disorder Type 2E NGS Genetic DNA Test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the disorder.

About the Test

The COG7 gene is involved in glycosylation, a process crucial for the proper functioning of various proteins in the body. Mutations or variations in the COG7 gene can lead to glycosylation disorder type 2E. Our NGS technology allows for the simultaneous analysis of multiple genes, enabling efficient identification of potential genetic causes of the disorder.

Importance of the Test

By identifying mutations or variations in the COG7 gene, the COG7 Gene Glycosylation Disorder Type 2E Genetic Test provides a definitive diagnosis for individuals suspected of having the disorder. This diagnosis is vital for guiding medical management and treatment decisions. Furthermore, the test results offer valuable information for genetic counseling and family planning.

Test Name COG7 Gene Glycosylation disorder type 2E Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COG7 Gene Glycosylation disorder type 2E NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2E
Test Details

The COG7 gene glycosylation disorder type 2E NGS genetic test is a genetic test that is used to identify mutations or variations in the COG7 gene. This gene is involved in a process called glycosylation, which is important for the proper functioning of various proteins in the body.

Mutations in the COG7 gene can lead to a glycosylation disorder, specifically type 2E. This disorder is characterized by a range of symptoms, including developmental delays, intellectual disability, seizures, and various physical abnormalities.

The NGS (next-generation sequencing) technology used in this genetic test allows for the analysis of multiple genes simultaneously, which can help to identify potential genetic causes of the disorder more efficiently.

By identifying mutations or variations in the COG7 gene, this test can provide a definitive diagnosis for individuals suspected of having a glycosylation disorder type 2E. This can be important for guiding medical management and treatment decisions, as well as providing information for genetic counseling and family planning.

SKU: TEST-2392 Category:

Related products